Invention Grant
- Patent Title: Procoagulant peptides
- Patent Title (中): 促凝剂肽
-
Application No.: US13238751Application Date: 2011-09-21
-
Publication No.: US08822638B2Publication Date: 2014-09-02
- Inventor: Friedrich Scheiflinger , Michael Dockal
- Applicant: Friedrich Scheiflinger , Michael Dockal
- Applicant Address: US IL Deerfield CH Glattpark (Opfikon)
- Assignee: Baxter International Inc.,Baxter Healthcare SA
- Current Assignee: Baxter International Inc.,Baxter Healthcare SA
- Current Assignee Address: US IL Deerfield CH Glattpark (Opfikon)
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: C07K7/00
- IPC: C07K7/00

Abstract:
A peptide or peptide derivative comprising: (i) WDLYFEIVW;(SEQ ID NO: 1) or (ii) a variant amino acid sequence comprising one, two, three or four L-amino acid substitutions in WDLYFEIVW (SEQ ID NO: 1); or (iii) the retro-inverso variant of the peptide or peptide derivative of either one of parts (i) and (ii), wherein said peptide or peptide derivative has procoagulant activity. A peptide or peptide derivative comprising: (i) an amino acid sequence comprising imfwydcye; or (ii) a variant amino acid sequence comprising one, two, three, four, five or six amino acid substitutions in imfwydcye, wherein said peptide or peptide derivative has procoagulant activity.
Public/Granted literature
- US20120077749A1 Biologically Active Peptides Public/Granted day:2012-03-29
Information query